Lyon Joseph Douglas's Form 4 filing
Corcept Therapeutics Inc (CORT) · filed Dec 5, 2023
- Accession no.
- 0000950170-23-068373
- Filed
- Dec 5, 2023
- Trade date
- Dec 1-4, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 1 derivative transaction. Open-market sales total $130.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lyon Joseph DouglasCIK 0001817838 | Officer (Chief Accounting Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2023 | Common Stock | MOption exerciseAcquired | +2,568 | $11.35 | +$29,146.8 | 8,422 | Direct | |
| Dec 1, 2023 | Common Stock | SSaleDisposed | −2,568 | $26.00 | −$66,768 | 5,854 | Direct | |
| Dec 4, 2023 | Common Stock | MOption exerciseAcquired | +2,432 | $11.35 | +$27,603.2 | 8,286 | Direct | |
| Dec 4, 2023 | Common Stock | SSaleDisposed | −2,432 | $26.00 | −$63,232 | 5,854 | Direct | |
| Dec 1, 2023 | Common Stock | AGrant or awardAcquired | +460 | $25.97F4 | +$11,946.2 | 6,314 | Direct | |
| Dec 1, 2023 | Common Stock | AGrant or awardAcquired | +460 | $0.00 | $0 | 6,774 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2023 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 44,167 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F4
In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase.
Referenced by the price of 1 transaction in Table I.